Intercept Pharma higher on activist chatter

Jul. 16, 2020 10:43 AM ETIntercept Pharmaceuticals, Inc. (ICPT)ICPTBy: Stephen Alpher, SA News Editor14 Comments
  • A rumor making the rounds says a large activist may be getting involved with Intercept Pharma (NASDAQ:ICPT) to push for sale.
  • Intercept disappointed in late June when it received a CRL from the FDA for its application for the use of obeticholic acid (OCA) to treat liver fibrosis due to nonalcoholic steatohepatitis (NASH). Shares fell about 40% that day, and have slipped a bit further since.
  • The stock's higher by 2.15% today.

Recommended For You

Comments (14)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.